Michel Gréco
Presidente en Centre Hospitalier Saint Joseph - Saint Luc .
Origen de la red de primer grado Michel Gréco.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
University of Western Ontario
35
| College/University | Other Consumer Services | 35 |
17
| Public Company | Biotechnology | 17 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria.
16
| Extinct | Pharmaceuticals: Major | 16 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA.
16
| Extinct | Biotechnology | 16 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.
13
| Non-Profit Organization | Pharmaceuticals: Major | 13 |
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France.
11
| Extinct | Pharmaceuticals: Other | 11 |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD.
11
| Subsidiary | Miscellaneous Commercial Services | 11 |
| Extinct | Pharmaceuticals: Major | 11 | |
Sciences Po
5
| College/University | Other Consumer Services | 5 |
Centre Hospitalier Saint Joseph - Saint Luc
2
| Private Company | 2 | |
Noraker SARL
 Noraker SARL Medical SpecialtiesHealth Technology Noraker SARL designs, produces and markets synthetic and absorbable biomaterial-based implantable medical devices. It offers dental surgery and orthopedic products. The firm's services include filling bone defects such as cyst and dental granuloma. The company was founded by Rachid Zenati in 2005 and is headquartered in Villeurbanne, France.
1
| Private Company | Medical Specialties | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michel Gréco a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BANK OF MONTREAL | Major Banks | Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Toronto | College/University | Corporate Officer/Principal Masters Business Admin Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| IOMAI CORPORATION | Biotechnology | Founder Director/Board Member Chief Executive Officer Director/Board Member | |
Institute of Corporate Directors
 Institute of Corporate Directors Miscellaneous Commercial ServicesCommercial Services The Institute of Corporate Directors is a not-for-profit, member-based association that serves as a resource and voice for directors and boards. The non-profit company is based in Toronto, Canada, and has subsidiaries in Canada. The ICD provides thought leadership through various publications and is a unified voice for directors. The Canadian company was founded by Brian J. Gibson, and Rahul K. Bhardwaj has been the CEO of the company since 2016. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| Intercell Austria AG | Director/Board Member Corporate Officer/Principal Director/Board Member Chief Executive Officer | ||
| University of Alberta | College/University | Undergraduate Degree Undergraduate Degree Director/Board Member | |
Biovertis AG
 Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Chairman Founder | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree Masters Business Admin Doctorate Degree | |
| McGill University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| HOOKIPA PHARMA INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer Founder | |
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Chief Executive Officer Chairman Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Université Laval | College/University | Graduate Degree Graduate Degree | |
| Vivalis Toyama Japan KK | Chairman Director/Board Member | ||
| VETOQUINOL SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Smol Therapeutics SAS | Chief Executive Officer Chairman | ||
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Director/Board Member Director/Board Member | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Groupe Grimaud La Corbière SA
 Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Chief Executive Officer Chairman | |
| SERES THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree Graduate Degree | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| Osgoode Hall Law School | College/University | Graduate Degree Graduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
| Carleton University | College/University | Graduate Degree Graduate Degree | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| RONA INC. | Home Improvement Chains | Director/Board Member Director/Board Member | |
Biotek Partenaires SAS
 Biotek Partenaires SAS Investment ManagersFinance Biotek Partenaires SAS (Biotek Partenaires) is a venture capital firm, a subsidiary of Banque Saint Olive. The firm is founded in 1998 by Saint-Olive. The firm headquartered in Lyon, France. | Investment Managers | Chairman President | |
| Collège Sainte-Marie | College/University | Undergraduate Degree Undergraduate Degree | |
Montréal Heart Institute
 Montréal Heart Institute Miscellaneous Commercial ServicesCommercial Services The Montréal Heart Institute is a highly specialized cardiology hospital located in Montréal, Canada. The institute is affiliated with the Université de Montréal and offers a range of services and facilities, including a biobank, a pharmacogenomics center, and the MHICC and Innovacor centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Valneva USA, Inc. | Chief Executive Officer Chief Executive Officer | ||
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The company is based in Kirkland, Canada. | Medical Distributors | President Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Chairman | |
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 19 |
| Canadá | 13 |
| Francia | 9 |
| Austria | 6 |
| Reino Unido | 3 |
Sectorial
| Health Technology | 19 |
| Consumer Services | 15 |
| Commercial Services | 7 |
| Finance | 3 |
| Government | 2 |
Operativa
| Director/Board Member | 506 |
| Corporate Officer/Principal | 220 |
| Chairman | 165 |
| Independent Dir/Board Member | 125 |
| President | 105 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| L. Ménard | 46 |
| Alain Munoz | 38 |
| William Campbell | 37 |
| Jamie Lewin | 35 |
| Frédéric Grimaud | 33 |
| Hans Lennart Rudolf Wigzell | 30 |
| Jean-Pierre Gorgé | 26 |
| Thomas D. Szucs | 23 |
| Donald Sheldon | 23 |
| Anne VanLent | 23 |
| James Sulat | 23 |
| Jean-René Halde | 22 |
| Anne-Marie Graffin | 22 |
| Franck Grimaud | 22 |
- Bolsa de valores
- Insiders
- Michel Gréco
- Conexiones Empresas